Epigenomics AG（EPGNF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · EPGNF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$0.02M	$0.00M	$0.34M	$0.48M	$6.20M
Cost of Revenue	$0.00M	$0.01M	$0.06M	$0.12M	$0.14M
Gross Profit	$0.00M	($0.01M)	$0.28M	$0.36M	$6.07M
Gross Margin %(computed)	0.00%	—	83.22%	75.26%	97.81%
Operating Expenses
R&D Expenses	$0.00M	$0.00M	$0.00M	$6.19M	$3.11M
G&A Expenses	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Total Operating Expenses	$0.36M	$1.13M	$4.78M	$12.42M	$8.42M
Operating Income	($0.34M)	($1.14M)	($4.18M)	($12.05M)	($2.35M)
Operating Margin %(computed)	—	—	—	—	-37.95%
Interest Income	$0.04M	$0.04M	$0.59M	$0.10M	$0.01M
Interest Expense	$0.00M	$0.00M	$0.00M	$0.15M	$0.05M
Income Before Tax	($0.31M)	($3.35M)	($4.46M)	($12.10M)	($2.41M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	($0.08M)	$0.02M
Net Income	($0.31M)	($3.35M)	($4.46M)	($12.02M)	($2.43M)
Net Margin %(computed)	—	—	—	—	-39.14%
Per Share & EBITDA
EPS (Basic)	$-0.36	$-3.82	$-5.23	$-14.78	$-4.33
Wtd Avg Shares	0.88M	0.88M	0.85M	0.81M	0.56M
EBITDA	($0.34M)	($3.34M)	($3.61M)	($11.22M)	($1.94M)
EBITDA Margin %(computed)	—	—	—	—	-31.26%